企業プロフィール
Journey Medical Corporation 株価・ニュース・カタリスト
- ティッカー:
- DERM
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
6.46 USD (-3.87%)
終値
最終更新: 2026年8月17日
166M USD
時価総額
株価変動の要因
As of Aug 17, 2026, DERM closed down 3.87% at $6.46. No new same-company headline was identified in the current news window.
企業概要
Prescription Dermatology Company
Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization.
Emrosi
Emrosi is an oral treatment for inflammatory lesions of rosacea and is central to Journey Medical's current commercial expansion. The product broadens the company's presence in a large chronic dermatology market.
Established Portfolio
Journey Medical markets nine branded prescription drugs for common skin conditions. This portfolio allows the same commercial infrastructure to support multiple products and physician relationships.
Focused Commercial Model
The company emphasizes targeted product acquisition and specialist promotion rather than maintaining a broad internal discovery platform. Journey Medical was founded by Fortress Biotech but operates as a separately listed company.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。